Cardot V, Berlizot P, Le Normand L
Département d'Urologie, Pôle de Santé du Plateau, 3, avenue de Villacoublay, 92360 Meudon, France.
Prog Urol. 2010 Feb;20 Suppl 2:S161-9. doi: 10.1016/S1166-7087(10)70012-9.
Precise regulations should be respected when using neuromodulation of the sacral nerve roots in treating urinary incontinence in women with vesical hyperactivity. It is not recommended to perform a neuromodulation test of the sacral roots in management of urinary incontinence caused by vesical hyperactivity if rehabilitation or anticholinergic treatment has not been attempted, unless a contraindication prevents use of these treatments. The urologist implanting the device will have had specific training on the implantation material, the implantation technique, and parameterization. Assessment of the efficacy during the test period should be rigorous and based on use of voiding diaries, symptom questionnaires, as well as the patient's overall evaluation. Improvement greater than 50% and a counter test verifying the reappearance of symptoms after stimulation is interrupted are necessary to warrant implantation of a neuromodulator. Complete information should be given to patients before the test is performed. This will detail the test procedure, how to keep a voiding diary, the safety precautions, and the incidents that may occur.
在使用骶神经根神经调节治疗膀胱活动亢进的女性尿失禁时,应遵循精确的规定。如果尚未尝试康复治疗或抗胆碱能治疗,除非存在禁忌证阻止使用这些治疗方法,否则不建议在治疗膀胱活动亢进引起的尿失禁时进行骶神经根神经调节测试。植入设备的泌尿科医生应接受过关于植入材料、植入技术和参数设置的专门培训。测试期间的疗效评估应严格进行,基于排尿日记、症状问卷以及患者的总体评价。改善超过50%且在刺激中断后进行反测试以验证症状再次出现,才足以保证植入神经调节器。在进行测试前,应向患者提供完整信息。这将详细说明测试程序、如何记录排尿日记、安全注意事项以及可能发生的事件。